Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.

<h4>Background</h4>Development of a competent collateral circulation in established coronary artery disease is cardio-protective. The vascular endothelial growth factor (VEGF) system plays a key role in this process. We investigated the prognostic performance of circulating VEGF-A and th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Barry R Palmer, Melinda A Paterson, Chris M Frampton, Anna P Pilbrow, Lorraine Skelton, Chris J Pemberton, Robert N Doughty, Chris J Ellis, Richard W Troughton, A Mark Richards, Vicky A Cameron
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6fa3494f411c4b08af18bcb3f58ba37b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6fa3494f411c4b08af18bcb3f58ba37b
record_format dspace
spelling oai:doaj.org-article:6fa3494f411c4b08af18bcb3f58ba37b2021-12-02T20:07:03ZVascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.1932-620310.1371/journal.pone.0254206https://doaj.org/article/6fa3494f411c4b08af18bcb3f58ba37b2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254206https://doaj.org/toc/1932-6203<h4>Background</h4>Development of a competent collateral circulation in established coronary artery disease is cardio-protective. The vascular endothelial growth factor (VEGF) system plays a key role in this process. We investigated the prognostic performance of circulating VEGF-A and three genetic variants in the VEGFA gene in a clinical coronary cohort.<h4>Methods and results</h4>The Coronary Disease Cohort Study (CDCS) recruited 2,140 patients, with a diagnosis of acute coronary syndrome (ACS), after admission to Christchurch or Auckland City Hospitals between July 2002 and January 2009. We present data for 1927 patients from the cohort genotyped for three SNPs in the VEGF-A gene, rs699947 (C-2578A), rs2010963 (C405G) and rs3025039 (C936T). Plasma VEGF-A concentrations were assayed in a subgroup (n = 550) of CDCS patients (geometric mean 36.6 [34.7-38.5] pg/ml). VEGF-A levels correlated with patient heart rate at baseline (p = 0.034). None of rs699947, rs3025039, nor rs2010963 genotypes were significantly associated with VEGF-A levels, but rs3025039 genotype was positively associated with collateral vessels perfusion according to the Rentrop classification (p = 0.01) and baseline natriuretic peptide levels (p<0.05). Survival in the CDCS cohort was independently associated with baseline VEGF-A levels and (in males) with rs699947 genotype.<h4>Conclusions</h4>This study is strongly suggestive that VEGF-A levels have value as a prognostic biomarker in coronary heart disease patients and SNPs in VEGF-A deserve further investigation as prognostic markers and indicators of angiogenic potential influencing the formation of collateral circulation.Barry R PalmerMelinda A PatersonChris M FramptonAnna P PilbrowLorraine SkeltonChris J PembertonRobert N DoughtyChris J EllisRichard W TroughtonA Mark RichardsVicky A CameronPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0254206 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Barry R Palmer
Melinda A Paterson
Chris M Frampton
Anna P Pilbrow
Lorraine Skelton
Chris J Pemberton
Robert N Doughty
Chris J Ellis
Richard W Troughton
A Mark Richards
Vicky A Cameron
Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.
description <h4>Background</h4>Development of a competent collateral circulation in established coronary artery disease is cardio-protective. The vascular endothelial growth factor (VEGF) system plays a key role in this process. We investigated the prognostic performance of circulating VEGF-A and three genetic variants in the VEGFA gene in a clinical coronary cohort.<h4>Methods and results</h4>The Coronary Disease Cohort Study (CDCS) recruited 2,140 patients, with a diagnosis of acute coronary syndrome (ACS), after admission to Christchurch or Auckland City Hospitals between July 2002 and January 2009. We present data for 1927 patients from the cohort genotyped for three SNPs in the VEGF-A gene, rs699947 (C-2578A), rs2010963 (C405G) and rs3025039 (C936T). Plasma VEGF-A concentrations were assayed in a subgroup (n = 550) of CDCS patients (geometric mean 36.6 [34.7-38.5] pg/ml). VEGF-A levels correlated with patient heart rate at baseline (p = 0.034). None of rs699947, rs3025039, nor rs2010963 genotypes were significantly associated with VEGF-A levels, but rs3025039 genotype was positively associated with collateral vessels perfusion according to the Rentrop classification (p = 0.01) and baseline natriuretic peptide levels (p<0.05). Survival in the CDCS cohort was independently associated with baseline VEGF-A levels and (in males) with rs699947 genotype.<h4>Conclusions</h4>This study is strongly suggestive that VEGF-A levels have value as a prognostic biomarker in coronary heart disease patients and SNPs in VEGF-A deserve further investigation as prognostic markers and indicators of angiogenic potential influencing the formation of collateral circulation.
format article
author Barry R Palmer
Melinda A Paterson
Chris M Frampton
Anna P Pilbrow
Lorraine Skelton
Chris J Pemberton
Robert N Doughty
Chris J Ellis
Richard W Troughton
A Mark Richards
Vicky A Cameron
author_facet Barry R Palmer
Melinda A Paterson
Chris M Frampton
Anna P Pilbrow
Lorraine Skelton
Chris J Pemberton
Robert N Doughty
Chris J Ellis
Richard W Troughton
A Mark Richards
Vicky A Cameron
author_sort Barry R Palmer
title Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.
title_short Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.
title_full Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.
title_fullStr Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.
title_full_unstemmed Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes.
title_sort vascular endothelial growth factor-a promoter polymorphisms, circulating vegf-a and survival in acute coronary syndromes.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/6fa3494f411c4b08af18bcb3f58ba37b
work_keys_str_mv AT barryrpalmer vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT melindaapaterson vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT chrismframpton vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT annappilbrow vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT lorraineskelton vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT chrisjpemberton vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT robertndoughty vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT chrisjellis vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT richardwtroughton vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT amarkrichards vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
AT vickyacameron vascularendothelialgrowthfactorapromoterpolymorphismscirculatingvegfaandsurvivalinacutecoronarysyndromes
_version_ 1718375310202765312